×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
SESSION 10: FDA’S ACTIONS ON THE ORIGINAL IND & FUTURE AMENDMENTS
Session Chair(s)
Michael Hamrell, PhD, RAC
President
MORIAH Consultants, United States
Speaker(s)
FDA’S ACTIONS ON THE ORIGINAL IND & FUTURE AMENDMENTS
Carol H. Danielson, DrPH, MS, RAC
Regulatory Advantage, LLC, United States
President
Michael Hamrell, PhD, RAC
MORIAH Consultants, United States
President
Have an account?